Pharmacy costs in outpatient care are growing fast in the U.S. They are increasing about 52% faster than total outpatient spending. This puts money pressure on healthcare groups that give care outside hospitals. For example, labor costs in healthcare rose by about 25.1% between 2019 and 2023. At the same time, non-labor costs like medicines went up by nearly 29.9%. Outpatient pharmacy expenses make up much of these non-labor costs.
Pharmacy spending in ambulatory care settings grows faster than in hospital acute care settings. It goes up by almost 3.96% per year. This happens because more prescriptions are filled in outpatient places and newer drugs cost more.
A challenge is knowing who pays for different medications. Provider-given drugs are usually covered under medical benefits. But drugs a patient gets and uses on their own are covered under pharmacy benefits. This split makes cost management harder and needs good coordination between billing, clinical, and pharmacy teams.
Also, higher outpatient pharmacy costs affect patient access and care quality. When medicine costs are high, patients may not take their medicines as they should. This can cause poor health results and more hospital visits. So, outpatient pharmacy management must both control costs and keep care quality good.
Pharmacists help control pharmacy costs and improve patient health in outpatient care. Medication Therapy Management (MTM) programs led by pharmacists show benefits. They help patients take medicines properly, fix medication problems, and lower bad drug reactions.
Studies by the Agency for Healthcare Research and Quality (AHRQ) found pharmacist-led MTM improves how medicines are used. This is true especially for older and high-risk patients. These programs lower hospital readmissions and emergency visits by improving drug plans and educating patients.
Pharmacists also help manage chronic diseases like diabetes. Their work improves measures such as blood sugar levels, blood pressure, and cholesterol. Giving pharmacists more roles, like consulting with patients and prescribing some medicines, leads to better control of diabetes. This helps reduce long-term healthcare costs by cutting complications.
One review of 21 studies on pharmacist care for diabetes showed consistent drops in blood sugar levels. These improvements help avoid problems such as kidney failure, nerve damage, and heart disease.
MTM programs also tackle “polypharmacy,” where patients take many medicines, sometimes unnecessarily. This can cause bad drug reactions and higher costs. Pharmacists review medication lists and work with doctors to reduce improper prescriptions.
Still, some barriers slow wider use of pharmacist-led MTM. These include limited ways to pay for services, uncertain doctor cooperation, and difficulty fitting pharmacists into primary care teams. Overcoming these needs careful planning and support from medical leaders and IT teams.
Managing pharmacy costs in outpatient care takes many steps. Medical practice leaders can use several strategies to keep costs down while keeping care good:
New technologies like artificial intelligence (AI) and automation help outpatient pharmacy work. They offer useful tools to run operations smoothly and control costs.
Experts say it is important to set up these technologies well and have support from experts. Otherwise, tech investments may not work as hoped.
Medical practice leaders and owners in outpatient care must align pharmacy cost management with their main goals. Careful planning for pharmacist-led services and automation can improve finances and patient care.
Pharmacy costs are rising as outpatient care grows in the U.S. Pharmacists provide many proven benefits through medication therapy management. Recent studies show better chronic disease results and cost savings. Combining these with AI and automation offers medical practices ways to control costs and improve care quality.
Administrators, owners, and IT managers should think about full strategies. These include detailed spending reviews, teamwork across fields, standardization, strong supplier ties, including pharmacists, and adopting new technology. Using these methods can handle the complex problem of outpatient pharmacy costs and support lasting, patient-focused healthcare.
Non-labor expenses include indirect spend, purchased services, pharmaceuticals, physician preference items, capital management, and medical, surgical, and lab expenses.
Indirect spend and purchased services comprise 20-25% of a health system’s total spend, and effective management can lead to significant cost savings of 10-15%.
Organizations should start small by standardizing purchases and implementing locked-down order guides to create momentum and build trust while achieving quick savings.
An in-depth spend analysis helps identify cost reduction opportunities by categorizing spend and considering regional factors, staffing, and operational constraints.
Engaging stakeholders across an organization ensures alignment in procurement strategies, uncovering hidden savings and enhancing accountability and transparency.
Standardization reduces supplier fragmentation and consolidates purchases, creating efficiency and opportunities for negotiation, leading to cost savings.
A TCO mindset evaluates hidden costs beyond initial price, such as maintenance and operational efficiencies, which influences more cost-effective procurement decisions.
Strong partnerships with suppliers can drive innovation and value, ultimately enhancing employee satisfaction and operational efficiency.
Outpatient pharmacy costs are rising rapidly, necessitating efficient management strategies as pharmacy services play a critical role in ambulatory care delivery.
Healthcare leaders should prepare for therapy shifts, leverage technology for operational efficiency, integrate pharmacy into patient care, and create interdisciplinary committees for oversight.
Simbo is using AI agents to automate all phone related workflows. Connect now to know more.
Schedule AI Agents Demo Now© Since 2019, Simbo AI.
